St. George's Respiratory Questionnaire: MCID
暂无分享,去创建一个
[1] P. Jones,et al. Quality of life in patients with chronic obstructive pulmonary disease , 2006 .
[2] E. Wouters,et al. Raised CRP levels mark metabolic and functional impairment in advanced COPD , 2005, Thorax.
[3] T. Gislason,et al. Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression , 2005, European Respiratory Journal.
[4] G. Norman,et al. The truly remarkable universality of half a standard deviation: confirmation through another look , 2004, Expert review of pharmacoeconomics & outcomes research.
[5] J. Vestbo. [Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease]. , 2004, Ugeskrift for laeger.
[6] P. Calverley,et al. Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease , 2003, European Respiratory Journal.
[7] G. Guyatt,et al. Evaluation of the minimal important difference for the feeling thermometer and the St. George's Respiratory Questionnaire in patients with chronic airflow obstruction. , 2003, Journal of clinical epidemiology.
[8] H Putter,et al. Correlation between annual change in health status and computer tomography derived lung density in subjects with α1-antitrypsin deficiency , 2003, Thorax.
[9] Ruth Etzioni,et al. Cost effectiveness of lung-volume-reduction surgery for patients with severe emphysema. , 2003, The New England journal of medicine.
[10] G. Norman,et al. Interpretation of Changes in Health-related Quality of Life: The Remarkable Universality of Half a Standard Deviation , 2003, Medical care.
[11] M. Tsukino,et al. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. , 2003, American journal of respiratory and critical care medicine.
[12] R. Pauwels,et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial , 2003, The Lancet.
[13] R. Sansores,et al. Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease , 2003, European Respiratory Journal.
[14] Jordi Alonso,et al. Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.
[15] P. Jones. Interpreting thresholds for a clinically significant change in health status in asthma and COPD , 2002, European Respiratory Journal.
[16] M. Ferrer,et al. Interpretation of quality of life scores from the St George's Respiratory Questionnaire , 2002, European Respiratory Journal.
[17] R. Zuwallack,et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease , 2002, European Respiratory Journal.
[18] J. V. van Noord,et al. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium , 2002, European Respiratory Journal.
[19] P. Jones,et al. Health status measurement in chronic obstructive pulmonary disease , 2001, Thorax.
[20] G. Guyatt,et al. Relation of Distribution- and Anchor-Based Approaches in Interpretation of Changes in Health-Related Quality of Life , 2001, Medical care.
[21] R. Dahl,et al. Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.
[22] P M Calverley,et al. Health status deterioration in patients with chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.
[23] S. Spencer,et al. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial , 2000, BMJ : British Medical Journal.
[24] N. Payne,et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial , 2000, The Lancet.
[25] P. Jones. Impact of lower respiratory tract infections on health status. , 2000, Seminars in respiratory and critical care medicine.
[26] P. Jones,et al. A comparison of global questions versus health status questionnaires as measures of the severity and impact of asthma. , 1999, The European respiratory journal.
[27] P. Jones,et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease , 1999, Thorax.
[28] P. Jones,et al. Analysis of factors that characterize health impairment in patients with chronic respiratory failure , 1999 .
[29] T. Seemungal,et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.
[30] M. Tsukino,et al. Comparison of Discriminative Properties among Disease-specific Questionnaires for Measuring Health-related Quality of Life in Patients with Chronic Obstructive Pulmonary Disease , 1998 .
[31] P. Jones,et al. Validation of the St. George's Respiratory Questionnaire in bronchiectasis. , 1997, American journal of respiratory and critical care medicine.
[32] P. Jones,et al. Quality of life changes in COPD patients treated with salmeterol. , 1997, American journal of respiratory and critical care medicine.
[33] J. G. Douglas,et al. Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. , 1997, Thorax.
[34] H. R. Anderson,et al. A computer-assisted telephone interview technique for assessment of asthma morbidity and drug use in adult asthma. , 1996, Journal of clinical epidemiology.
[35] M. Connolly,et al. Impact of obstructive airways disease on quality of life in older adults. , 1996, Thorax.
[36] E. Wouters,et al. Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease. , 1996, Thorax.
[37] P. Jones,et al. Quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia. , 1996, Thorax.
[38] P. Jones,et al. Quality of life, symptoms and pulmonary function in asthma: long-term treatment with nedocromil sodium examined in a controlled multicentre trial. Nedocromil Sodium Quality of Life Study Group. , 1994, The European respiratory journal.
[39] P. Jones,et al. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. , 1992, The American review of respiratory disease.
[40] P. Jones,et al. The St George's Respiratory Questionnaire. , 1991, Respiratory medicine.
[41] P. Jones,et al. Influence of demographic and disease related factors on the degree of distress associated with symptoms and restrictions on daily living due to asthma in six countries. , 1991, The European respiratory journal.
[42] P. Jones,et al. Patients' perception of distress due to symptoms and effects of asthma on daily living and an investigation of possible influential factors. , 1990, Clinical science.
[43] G. Guyatt,et al. Measurement of health status. Ascertaining the minimal clinically important difference. , 1989, Controlled clinical trials.